| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/20/2001 | EP1107784A2 Activation and protection of t-cells (cd4?+ and cd8?+ ) using an h 2? receptor agonist and other t-cell activating agents |
| 06/20/2001 | EP1107783A1 Method for inducing a cell-mediated immune response and parenteral vaccine formulations therefor |
| 06/20/2001 | EP1107782A1 Oral vaccine compositions |
| 06/20/2001 | EP1107777A1 Stabilized pharmaceutical composition in lyophilized form |
| 06/20/2001 | EP1107776A1 Dry extract of henna, method for producing said extract and use of the same |
| 06/20/2001 | EP1107772A2 Probiotic, lactic acid-producing bacteria and uses thereof |
| 06/20/2001 | EP1107767A2 Use of selenium for treating patients suffering from systemic inflammatory response syndrome (sirs), and composition for implementing said treatment |
| 06/20/2001 | EP1107766A2 Use of lithium gluconate for making a medicine for treating herpes and seborrheic dermatitis |
| 06/20/2001 | EP1107758A2 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase |
| 06/20/2001 | EP1107756A1 Novel isoxazolinone antibacterial agents |
| 06/20/2001 | EP1107741A1 Orally administered controlled drug delivery system providing temporal and spatial control |
| 06/20/2001 | EP1107738A1 Novel pharmaceutical salt form |
| 06/20/2001 | EP1107722A2 A method for the treatment of staphylococcal disease |
| 06/20/2001 | EP0889902B1 Antibiotic peptides from bovine milk |
| 06/20/2001 | EP0796260B1 Rapamycin 42-oximes and hydroxylamines |
| 06/20/2001 | EP0768308B1 derivatives of pyroglutaminic acid, preparation process and applications |
| 06/20/2001 | EP0733043B1 Tricyclic derivatives and their use in pharmaceuticals |
| 06/20/2001 | EP0662157B1 Compositions and methods for treatment of hepatitis c virus-associated diseases |
| 06/20/2001 | CN1300291A Modulators of protein tyrosine phosphatases |
| 06/20/2001 | CN1300290A Novel cephalosporin compounds, processes for preparation thereof and antimicrobial compositions containing the same |
| 06/20/2001 | CN1300288A Water soluble azoles as broad-spectrum antifungals |
| 06/20/2001 | CN1300287A Water soluble azoles as broad-spectrum antifungals |
| 06/20/2001 | CN1300282A Pyrazole derivatives as P-38 MAP kinase inhibitors |
| 06/20/2001 | CN1300278A Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 06/20/2001 | CN1300222A Strategically modified hepatitis b core proteins and their derivatives |
| 06/20/2001 | CN1300216A Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts of hydrates |
| 06/20/2001 | CN1300210A Hydroxamic acid derivatives as antibacterials |
| 06/20/2001 | CN1299973A HCV-free-blood external preparing method |
| 06/20/2001 | CN1299680A Dressing for treating infantile bronchitis and pulmonitis and its preparation |
| 06/20/2001 | CN1299679A Arthralgia treating prescription |
| 06/20/2001 | CN1299669A Chinese medicine for treating several kinds of common ailment |
| 06/20/2001 | CN1299666A Wuxiangxiehuoling for purging fire-evil |
| 06/20/2001 | CN1067405C Indocalamus-leaf polyose sulfate and preparation process therefor |
| 06/20/2001 | CN1067258C Yangtao root and use of its effective part |
| 06/19/2001 | US6248787 Reducing cachexia |
| 06/19/2001 | US6248785 IL-8 receptor antagonists |
| 06/19/2001 | US6248755 Antiinflammatory agents; antiallergens; autoimmune diseases |
| 06/19/2001 | US6248753 Bicyclic compounds |
| 06/19/2001 | US6248744 Administering an analgesic dosage of an aminoalkenyl(pyridine or pyrimidine) derivative to relieve pain of menstruation, ovulation, pregnancy, childbirth, cancer, bone disorders, or injuries |
| 06/19/2001 | US6248739 Quinolinecarboxamides as antiviral agents |
| 06/19/2001 | US6248736 Dna polymerase inhibitors effective against herpesviruses |
| 06/19/2001 | US6248594 Kinesin-like motor protein |
| 06/19/2001 | US6248582 Gene deleted recombinant FeLV proviral DNA for production of vaccines against FeLV |
| 06/19/2001 | US6248576 Histidinol dehydrogenase |
| 06/19/2001 | US6248557 RatC |
| 06/19/2001 | US6248556 Nucleotide sequence of guanosine triphosphate-binding protein from staphylococcus; diagnosis of infections; drug screening; bactericides; bacteriostats; vaccines; probes; primers; vectors; host cells |
| 06/19/2001 | US6248551 Helicobacter aliphatic amidase AmiE polypeptides, and DNA sequences encoding those polypeptides |
| 06/19/2001 | US6248517 Amino acid sequences; diagnosis of lyme disease; recombinant production; vaccines |
| 06/19/2001 | US6248371 Tuberculosis |
| 06/19/2001 | US6248363 Improved delivery of hydrophilic or hydrophobic pharmaceutical active ingredients, such as drugs, nutraceuticals, cosmeceuticals and diagnostic agents |
| 06/19/2001 | US6248346 Chewing gum and production of the same |
| 06/19/2001 | US6248343 Mixture of triclosan and plant extract |
| 06/19/2001 | US6248328 HIV-1 virus isolates of a subtype and its differential diagnostics, a vaccine against HIV-1 virus infections of this subtype and method of producing same, use of the HIV-1 virus isolates |
| 06/19/2001 | US6248322 Attenuated vaccine for Blastomyces dermatitidis |
| 06/19/2001 | CA2136447C Selective cell inactivation in blood |
| 06/19/2001 | CA2028048C Derivatives of 1,4-dideoxy-1,4-imino-d-mannitol |
| 06/19/2001 | CA2022539C Albumin derivatives with therapeutic functions |
| 06/19/2001 | CA2003307C Streptolysin o antigen derivative, its production and uses |
| 06/14/2001 | WO2001042484A1 Il-6 like polynucleotide |
| 06/14/2001 | WO2001042471A2 Polypeptides and polynucleotides encoding same |
| 06/14/2001 | WO2001042457A2 Uncharged antisense oligonucleotides targeted to bacterial 16s and 23s prnas and their uses |
| 06/14/2001 | WO2001042450A1 Antibody binding to human airway trypsin-like enzyme and utilization thereof |
| 06/14/2001 | WO2001042449A2 Methods for introducing genes into mammalian subjects |
| 06/14/2001 | WO2001042429A1 Infection of eukaryotic cells with viruses in vitro |
| 06/14/2001 | WO2001042368A1 Substituted phthalocyanines and their precursors |
| 06/14/2001 | WO2001042308A2 Methods and compositions useful for inhibiting ccr5-dependent infection of cells by hiv-1 |
| 06/14/2001 | WO2001042305A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | WO2001042301A1 Interferon-alpha induced gene |
| 06/14/2001 | WO2001042299A2 Hepatitis virus sentinel virus i (svi) |
| 06/14/2001 | WO2001042288A2 G-protein coupled receptors |
| 06/14/2001 | WO2001042256A1 ANALOGS OF (1S, cis)-4-(2-AMINO-9H-PURIN-9-YL)-2-CYCLOPENTENE-1-METHANOL AS ANTIVIRAL |
| 06/14/2001 | WO2001042255A1 (1R,CIS)-4-(4-AMINO-7H-PYRROLO'2,3-I(D) ! PYRIMIDINE-7-YL)-2-CYCLOPENTENE-1-METHANOL DERIVATIVES AS ANTIVIRAL |
| 06/14/2001 | WO2001042242A1 Antibacterial heterobicyclic substituted phenyl oxazolidinones |
| 06/14/2001 | WO2001042241A1 Substituted pyridazines having cytokine inhibitory activity |
| 06/14/2001 | WO2001042238A1 Heterocyclic derivatives |
| 06/14/2001 | WO2001042229A1 Antibacterial amidinomethyl- and guanidinomethyl-oxazolidinones |
| 06/14/2001 | WO2001042222A1 Polymorphic crystalline forms of celecoxib |
| 06/14/2001 | WO2001042221A1 Solid-state form of celecoxib having enhanced bioavailability |
| 06/14/2001 | WO2001042216A2 Caspase inhibitors and uses thereof |
| 06/14/2001 | WO2001042210A1 Amycomycin, a process for its production and its use as a pharmaceutical |
| 06/14/2001 | WO2001042189A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) |
| 06/14/2001 | WO2001041810A2 Nucleic acid delivery system |
| 06/14/2001 | WO2001041808A1 Medicinal compositions for oral use |
| 06/14/2001 | WO2001041800A2 Compositions and methods for stabilizing biological molecules upon lyophilization |
| 06/14/2001 | WO2001041799A1 Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions |
| 06/14/2001 | WO2001041792A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | WO2001041785A2 Enzyme treatment for infection |
| 06/14/2001 | WO2001041782A2 Method for administering a cytokine to the central nervous system and the lymphatic system |
| 06/14/2001 | WO2001041780A2 Use of an immunosuppressant for increasing an antifugal activity of a lipopeptide |
| 06/14/2001 | WO2001041774A1 Haemostatic bactericidal compositions |
| 06/14/2001 | WO2001041765A1 Compositions containing itraconazole with improved bioavailability and narrow intra- and inter-individual variation of its absorption |
| 06/14/2001 | WO2001041760A2 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 06/14/2001 | WO2001041758A2 Valnemulin formulation |
| 06/14/2001 | WO2001041742A2 Antiviral medication |
| 06/14/2001 | WO2001041702A2 Zinc thiosalicylate, dermatological compositions containing same, in particular in the form of a self-adhesive device and method for preparing same |
| 06/14/2001 | WO2001041573A1 Therapeutic antimicrobial compositions |
| 06/14/2001 | WO2001041567A1 Deep penetrating antimicrobial compositions |
| 06/14/2001 | WO2001041536A2 Solid-state form of celecoxib having enhanced bioavailability |
| 06/14/2001 | WO2001041534A2 Pseudomycin phosphate prodrugs |
| 06/14/2001 | WO2001028552A3 Antimicrobial compositions comprising pyroglutamic acid and optionally metal salts |